Question 1

Which one of the following product recalls is the most serious?

Accepted Answer

A) Class 1 
B) Class 2 
C) Class 3 
D) Class 4 
A) Class 1 
B) Class 2 
C) Class 3 
D) Class 4

Question 2

Individual states cannot establish which of the following?

Accepted Answer

A) Storage of certain controlled substances 
B) Record keeping of certain controlled substances 
C) OTC status of some schedule C-V medications 
D) Schedule under which a drug should be placed 
A) Storage of certain controlled substances 
B) Record keeping of certain controlled substances 
C) OTC status of some schedule C-V medications 
D) Schedule under which a drug should be placed

Question 3

Which set(s) of numbers in the NDC code is(are) assigned by the drug company?

Accepted Answer

A) First set (labeler code) 
B) Second set (product code) 
C) Third set (package code) 
D) B and C 
A) First set (labeler code) 
B) Second set (product code) 
C) Third set (package code) 
D) B and C

Question 4

Which of the following involved the setup of the five-level schedule of controlled substances?

Accepted Answer

A) 1951 Durham-Humphrey Amendment 
B) 1962 Kefauver-Harris Amendments 
C) 1970 Comprehensive Drug Abuse Prevention and Control Act 
D) 1972 Drug Listing Act 
A) 1951 Durham-Humphrey Amendment 
B) 1962 Kefauver-Harris Amendments 
C) 1970 Comprehensive Drug Abuse Prevention and Control Act 
D) 1972 Drug Listing Act

Question 5

The first set of numbers of a National Drug Code (NDC) number, which is assigned by the FDA, is the:

Accepted Answer

A) Labeler code 
B) Product code 
C) Package code 
D) None of the above 
A) Labeler code 
B) Product code 
C) Package code 
D) None of the above

Question 6

DUEs required under OBRA 90 must include all of the following except:

Accepted Answer

A) Possible drug interactions 
B) Appropriateness of dosage and duration of therapy 
C) Evaluation of lower cost therapies 
D) Contraindications 
A) Possible drug interactions 
B) Appropriateness of dosage and duration of therapy 
C) Evaluation of lower cost therapies 
D) Contraindications

Question 7

The OBRA of 1990 federal counseling rules specifically state that the pharmacist must offer to counsel all:

Accepted Answer

A) Insured persons with new prescriptions 
B) Persons with new prescriptions 
C) Persons with new prescriptions or new instructions for old prescriptions 
D) Medicaid patients who receive new prescriptions 
A) Insured persons with new prescriptions 
B) Persons with new prescriptions 
C) Persons with new prescriptions or new instructions for old prescriptions 
D) Medicaid patients who receive new prescriptions

Question 8

What is the maximum number of refills allowed for schedules C-III and C-IV prescriptions?

Accepted Answer

A) Whatever the physician writes 
B) None 
C) Five refills within 6 months of the date the prescription was written 
D) Five refills within 6 months of the date of the original fill 
A) Whatever the physician writes 
B) None 
C) Five refills within 6 months of the date the prescription was written 
D) Five refills within 6 months of the date of the original fill

Question 9

How many times can schedules C-III, C-IV, and C-V prescriptions be transferred?

Accepted Answer

A) None 
B) One 
C) Until the refills have expired 
D) None of the above 
A) None 
B) One 
C) Until the refills have expired 
D) None of the above

Question 10

What is the first letter in the DEA number of prescribers who are qualified to prescribe medication to treat opioid addiction?

Accepted Answer

A) B 
B) F 
C) M 
D) X 
A) B 
B) F 
C) M 
D) X

Question 11

In which of the following forms can prescriptions for schedules C-II through C-V drugs be accepted by the pharmacy?

Accepted Answer

A) Written 
B) Orally 
C) Facsimile 
D) All of the above 
A) Written 
B) Orally 
C) Facsimile 
D) All of the above

Question 12

Which of the following would be a correct DEA number for Dylan Brown, MD?

Accepted Answer

A) MB1234563 
B) BB1234564 
C) AB1234563 
D) MD1234563 
A) MB1234563 
B) BB1234564 
C) AB1234563 
D) MD1234563

Question 13

Medicare insures individuals:

Accepted Answer

A) Over 65 years of age 
B) Under 65 years of age with long-term disabilities 
C) With end-stage renal disease 
D) All of the above 
A) Over 65 years of age 
B) Under 65 years of age with long-term disabilities 
C) With end-stage renal disease 
D) All of the above

Question 14

The purchase of pseudoephedrine is limited to:

Accepted Answer

A) 3.6 g per calendar day 
B) 9 g per 30 days from a retailer 
C) 7.5 g per 30 days by mail order 
D) All of the above 
A) 3.6 g per calendar day 
B) 9 g per 30 days from a retailer 
C) 7.5 g per 30 days by mail order 
D) All of the above

Question 15

Which of the following is(are) true of schedule C-I drugs?

Accepted Answer

A) C-I drugs have no approved medicinal use. 
B) These medications include lysergic acid diethylamide (LS
D)  and heroin. 
C) C-I drugs are not stocked in pharmacies. 
D) All of the above statements are true. 
A) C-I drugs have no approved medicinal use. 
B) These medications include lysergic acid diethylamide (LS
D)  and heroin. 
C) C-I drugs are not stocked in pharmacies. 
D) All of the above statements are true.

Question 16

The FDA is currently under the authority of the:

Accepted Answer

A) Department of Health, Education, and Welfare (HEW) 
B) Public Health Service 
C) Department of Health and Human Services 
D) Department of Agriculture 
A) Department of Health, Education, and Welfare (HEW) 
B) Public Health Service 
C) Department of Health and Human Services 
D) Department of Agriculture

Question 17

Which of the following is not considered a HIPAA-covered entity?

Accepted Answer

A) Health care provider 
B) Family member 
C) Health plan 
D) Health care clearinghouse 
A) Health care provider 
B) Family member 
C) Health plan 
D) Health care clearinghouse

Question 18

Form 222 consists of three copies. Which copy is ultimately sent to the DEA?

Accepted Answer

A) Top copy (1) 
B) Middle copy (2) 
C) Bottom copy (#) 
D) B and C 
A) Top copy (1) 
B) Middle copy (2) 
C) Bottom copy (#) 
D) B and C

Question 19

DUE stands for:

Accepted Answer

A) Drug use examination 
B) Data use evaluation 
C) Data usage evaluation 
D) Drug utilization evaluation 
A) Drug use examination 
B) Data use evaluation 
C) Data usage evaluation 
D) Drug utilization evaluation

Question 20

How often does the DEA require a narcotic inventory?

Accepted Answer

A) Every month 
B) Every 6 months 
C) Every year 
D) Every 2 years 
A) Every month 
B) Every 6 months 
C) Every year 
D) Every 2 years

Exam 2: Pharmacy Law, Ethics, and Regulatory Agencies

Which one of the following product recalls is the most serious?

Individual states cannot establish which of the following?

Which set(s) of numbers in the NDC code is(are) assigned by the drug company?

Which of the following involved the setup of the five-level schedule of controlled substances?

The first set of numbers of a National Drug Code (NDC) number, which is assigned by the FDA, is the:

DUEs required under OBRA 90 must include all of the following except:

The OBRA of 1990 federal counseling rules specifically state that the pharmacist must offer to counsel all:

What is the maximum number of refills allowed for schedules C-III and C-IV prescriptions?

How many times can schedules C-III, C-IV, and C-V prescriptions be transferred?

What is the first letter in the DEA number of prescribers who are qualified to prescribe medication to treat opioid addiction?

In which of the following forms can prescriptions for schedules C-II through C-V drugs be accepted by the pharmacy?

Which of the following would be a correct DEA number for Dylan Brown, MD?

Medicare insures individuals:

The purchase of pseudoephedrine is limited to:

Which of the following is(are) true of schedule C-I drugs?

The FDA is currently under the authority of the:

Which of the following is not considered a HIPAA-covered entity?

Form 222 consists of three copies. Which copy is ultimately sent to the DEA?

DUE stands for:

How often does the DEA require a narcotic inventory?

History of Medicine and Pharmacy

Competencies, Associations, and Settings for Technicians

Communication and Role of the Technician With the Customerpatient

Dosage Forms and Routes of Administration

Conversions and Calculations

Drug Information References

Community Pharmacy Practice

Institutional Pharmacy Practice

Additional Pharmacy Practice Settings

Bulk Repackaging and Non-Sterile Compounding

Aseptic Technique and Sterile Compounding

Pharmacy Billing and Inventory Management

Medication Safety and Error Prevention

Therapeutic Agents for the Nervous System

Therapeutic Agents for the Endocrine System

Therapeutic Agents for the Musculoskeletal System

Therapeutic Agents for the Cardiovascular System

Therapeutic Agents for the Respiratory System

Therapeutic Agents for the Gastrointestinal System

Therapeutic Agents for the Renal System

Therapeutic Agents for the Reproductive System

Therapeutic Agents for the Immune System

Therapeutic Agents for the Eyes, Ears, Nose, and Throat

Therapeutic Agents for the Dermatologic System

Therapeutic Agents for the Hematologic System

Over-The Counter OTC Medications

Complementary and Alternative Medicine Cam

Filters